Marksans Pharma informs about disclosure

19 Aug 2021 Evaluate

Pursuant to SEBI Circular No. SEBI/HO/ISD/CIR/P/2020/135 dated July 23, 2020, Marksans Pharma has informed that it enclosed reporting of violations related to Code of Conduct framed under SEBI (PIT) Regulations, 2015 by one Designated Person of the Company in the prescribed formats.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

162.20 -0.90 (-0.55%)
27-Jan-2026 11:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.70
Dr. Reddys Lab 1243.20
Cipla 1308.00
Zydus Lifesciences 892.60
Lupin 2151.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×